Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Immunotoxicology
|
September 15, 2011
Safety assessment of immunomodulatory biologics: the promise and challenges of regulatory T-cell modulation
Rafael A Ponce
Expert Opinion on Drug Metabolism & Toxicology
|
April 13, 2007
Toxicity as a result of immunostimulation by biologics
Elizabeth J Gribble, Pallavar V Sivakumar, Rafael A Ponce, et al.
Toxicology and Applied Pharmacology
|
January 30, 2002
p21(WAF1/CIP1) inhibits cell cycle progression but not G2/M-phase transition following methylmercury exposure
Ma Aileen C Mendoza, Rafael A Ponce, Ying C Ou, et al.
Brain Research. Developmental Brain Research
|
March 20, 2003
Changes in cell cycle parameters and cell number in the rat midbrain during organogenesis
Thomas A Lewandowski, Rafael A Ponce, Jay S Charleston, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 22, 2011
Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells
Xiaozhong Yu, Jaspreet S Sidhu, Sungwoo Hong, et al.
Environmental Health Perspectives
|
November 12, 2002
Investigations of methylmercury-induced alterations in neurogenesis
Elaine M Faustman, Rafael A Ponce, Ying C Ou, et al.
Journal of Immunotoxicology
|
June 11, 2013
Immunomodulation and lymphoma in humans
Rafael A Ponce, Thomas Gelzleichter, Helen G Haggerty, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 28, 2005
Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells
Jaspreet S Sidhu, Rafael A Ponce, Melinda A Vredevoogd, et al.
Toxicologic Pathology
|
July 23, 2005
Preclinical safety and pharmacokinetics of recombinant human factor XIII
Rafael A Ponce, Jennifer E Visich, Jane K Heffernan, et al.
Toxicologic Pathology
|
May 18, 2010
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations
John L Vahle, Gregory L Finch, Shawn M Heidel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Immunotoxicology
|
September 15, 2011
Safety assessment of immunomodulatory biologics: the promise and challenges of regulatory T-cell modulation
Rafael A Ponce
Expert Opinion on Drug Metabolism & Toxicology
|
April 13, 2007
Toxicity as a result of immunostimulation by biologics
Elizabeth J Gribble, Pallavar V Sivakumar, Rafael A Ponce, et al.
Toxicology and Applied Pharmacology
|
January 30, 2002
p21(WAF1/CIP1) inhibits cell cycle progression but not G2/M-phase transition following methylmercury exposure
Ma Aileen C Mendoza, Rafael A Ponce, Ying C Ou, et al.
Brain Research. Developmental Brain Research
|
March 20, 2003
Changes in cell cycle parameters and cell number in the rat midbrain during organogenesis
Thomas A Lewandowski, Rafael A Ponce, Jay S Charleston, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 22, 2011
Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells
Xiaozhong Yu, Jaspreet S Sidhu, Sungwoo Hong, et al.
Environmental Health Perspectives
|
November 12, 2002
Investigations of methylmercury-induced alterations in neurogenesis
Elaine M Faustman, Rafael A Ponce, Ying C Ou, et al.
Journal of Immunotoxicology
|
June 11, 2013
Immunomodulation and lymphoma in humans
Rafael A Ponce, Thomas Gelzleichter, Helen G Haggerty, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 28, 2005
Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells
Jaspreet S Sidhu, Rafael A Ponce, Melinda A Vredevoogd, et al.
Toxicologic Pathology
|
July 23, 2005
Preclinical safety and pharmacokinetics of recombinant human factor XIII
Rafael A Ponce, Jennifer E Visich, Jane K Heffernan, et al.
Toxicologic Pathology
|
May 18, 2010
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations
John L Vahle, Gregory L Finch, Shawn M Heidel, et al.
Page
of 2